The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictors of differential outcomes according to response to induction chemotherapy in high-risk neuroblastoma.
 
Elizabeth Sokol
No Relationships to Disclose
 
Brian LaBarre
No Relationships to Disclose
 
Arlene Naranjo
Consulting or Advisory Role - Novartis
 
Navin R. Pinto
No Relationships to Disclose
 
Susan G. Kreissman
Leadership - Allterum Therapeutics (I); Champions Oncology (I)
Stock and Other Ownership Interests - Champions Oncology (I); Newave Pharmaceutical (I)
Consulting or Advisory Role - AiCure (I); Allterum Therapeutics (I); Champions Oncology (I); Grid Therapeutics (I); Newave Pharmaceutical (I)
 
Meaghan Granger
No Relationships to Disclose
 
Julie R. Park
No Relationships to Disclose
 
Rochelle Bagatell
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Steven G. DuBois
Consulting or Advisory Role - Amgen; Bayer
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc